Among the products submitted to the FDA, two products are voucher recipients under the new Commissioners National Priority Voucher (CNPV) pilot as products with significant potential to address a major national priority
Beutler E, Moroose R, Kramer L, Gelbart T, Forman L: Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia
Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-on to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial
References Rossino G, Marchese E, Galli G, et al
Ten ul of CCK-8 solution in 100 ul culture medium was added to the wells before a 2 h incubation at 37 C